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Diabetes mellitus is a major health concern for human. The 
World Health Organization reports that approximately 171 mil-
lion people worldwide have diabetes mellitus and this number 
may double by the year 2030. Diabetic Peripheral Neuropathy 
(DPN) is the most common complication of  diabetic which af-
fects up to 50% of  patients with diabetes and represents a major 
cause of  morbidity and increased mortality. Moreover, health-care 
costs and personal associated with diabetic neuropathy are high. 
The pathogenesis of  DPN is multifactorial with the main catego-
ries being metabolic and ischemic but remains unclear. Hyper-
glycemia remains the key factor underlying diabetic neuropathy 
in addition to other changes like hypertriglyceridaemia, obesity, 
hypertension and dyslipidemia [1]. Actually, the tight glucose 
control and pain management are the only treatments available 
for DPN. Pharmacological treatment of  painful DPN includes 
tricyclic compounds, serotonin-norepinephrine reuptake inhibi-
tors, anticonvulsants, opiates, membrane stabilizers, the antioxi-
dant alpha lipoic acid and others [2]. While these medications are 
known to make advances in DPN control and improve quality of  
life, the licensed drugs for neuropathic pain are reported to have 
adverse effects. Recently, the demonstration of  neuroprotective 
properties of  some complementary and alternative medicines has 
drawn intensive interest [3]. Alternative or complementary treat-
ments may be helpful for some symptoms and include botanical 
therapies, acupuncture, physical medicine, magnetic therapy and 
yoga. In particular, among the many alternative medicines, several 
natural herbal products herbs may cure and control neuropathic 
pain. However, few of  them have been assessed with clinical trials 
for treating DPN. 
Many areas of  research into DPN are yet to be fully explored, 
but there are many challenges for researchers to determine the 
exact underlying and complex mechanisms of  DPN pathogenesis 
in order to control and cure this disease with efficient efficacy and 
safety. Finally, the first step in the treatment of  DPN remains the 
prevention.
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